Clinical Trials Directory

Trials / Sponsors / Artgen Biotech

Artgen Biotech

Academic / Other · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
UnknownSafety, Tolerability and Immunogenicity of Recombinant COVID-19 Vaccine Betuvax-CoV-2
COVID-19
Phase 1 / Phase 22021-10-14
Enrolling By InvitationClinical, Immunological, Morphological and Genetic Characteristics of Patients With Dysferlinopathy (LGMD R2)
Dysferlinopathy, Miyoshi Myopathy, LGMDR2
—2020-01-15
CompletedSafety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Diabetic Foot
Ulcers Related to Diabetic Foot Syndrome
N/A2015-08-01
UnknownSafety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Peripheral Nerve Injury
Peripheral Nerve Injury
Phase 1 / Phase 22015-04-01
UnknownSafety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's Phenomenon
Secondary Raynaud's Phenomenon
Phase 1 / Phase 22015-03-01
CompletedNon-Interventional Post Marketing Surveillance Study of Neovasculgen® in Patients With Chronic Lower Limb Isch
Lower Limb Ischemia
Phase 42012-09-01
CompletedEfficiency, Safety and Portability of Neovasculgen
Peripheral Arterial Disease
Phase 2 / Phase 32010-02-01